drugset / Trial / NCT00254813

Fast Titration Of Quetiapine Versus Currently Approved Titration

NCT00254813

Phase 3 Completed 150 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of a more rapid dose titration in acute schizophrenic patients compared to the conventional titration.

Timeline

Start
2004-10
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule

Indications